Cargando…
Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
Autores principales: | Hoda, Mir Alireza, Klikovits, Thomas, Klepetko, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926649/ https://www.ncbi.nlm.nih.gov/pubmed/29719730 http://dx.doi.org/10.1136/esmoopen-2018-000366 |
Ejemplares similares
-
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
por: Sinn, Katharina, et al.
Publicado: (2022) -
Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)
por: Geltner, Christian, et al.
Publicado: (2016) -
The landscape of small cell lung cancer metastases: Organ specificity and timing
por: Megyesfalvi, Zsolt, et al.
Publicado: (2021) -
Audit: time to rethink
por: Fulton, Raymond
Publicado: (1997) -
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
por: Hoda, Mir Alireza, et al.
Publicado: (2016)